Intel stock extends gains after report of possible U.S. government stake
Director Kenneth A. Burdick of LifeStance Health Group, Inc. (NASDAQ:LFST) recently purchased shares of common stock in multiple transactions. The purchases, all marked with transaction code "P", totaled $498,293, with prices ranging from $4.3 to $4.54. The stock, currently trading at $4.66, has shown strong momentum with a 17.48% gain over the past week. According to InvestingPro analysis, LFST appears undervalued at current levels.
On August 8, 2025, Burdick acquired 45,870 shares at $4.36 per share and 1,800 shares at $4.31 per share, increasing his direct ownership. On the same day, Burdick also acquired 46,511 shares at $4.30 per share through Burdick Family LLC, indicating indirect ownership. On August 11, 2025, he purchased 1,340 shares at $4.35 per share and 18,660 shares at $4.54 per share, further increasing his direct ownership. Analysts maintain a bullish outlook on the company, which is expected to turn profitable this year.
Following these transactions, Burdick directly owns 3,436,571 shares of LifeStance Health Group, Inc. common stock, representing a significant stake in the $1.82 billion market cap company. Get deeper insights into LFST’s valuation and growth prospects with InvestingPro’s comprehensive research report.
In other recent news, LifeStance Health Group Inc. reported its earnings for the second quarter of 2025, revealing a mixed financial performance. The company achieved an earnings per share (EPS) of -$0.01, surpassing analysts’ forecasted EPS of -$0.03. Revenue for the quarter reached $345 million, slightly exceeding the expected $345.05 million, and marking an 11% increase compared to the previous year. Despite these positive results, the company’s stock experienced a modest decline in pre-market trading. These developments are part of LifeStance Health’s ongoing financial performance updates.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.